Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit — Ger-SP  

Infection, Hospital Clinical Trial

Official title: Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae (ESBLE) in a Geriatric Unit: an Interventional Prospective Noninferiority Non-randomized Double-blind Controlled Before and After Study

Status Recruiting

Clinical Trial Summary

This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study. The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae acquired in geriatric units before and after discontinuing contact precautions.

Clinical Trial Description

Healthcare-associated infections (HAIs) are one of the main causes of morbidity and mortality worldwide. Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae have become microorganisms frequently found in HAIs, which reduces the therapeutic possibilities. ;

Related Conditions & MeSH terms

• Cross Infection
• Infection, Hospital

• NCT number: NCT05475574
• Study type: Interventional
• Source: Centre Hospitalier Régional Metz-Thionville
• Contact: Laurie RENAUDIN, MD
• Phone: 03 87 55 30 25
• Email: l.renaudin@chr-metz-thionville.fr
• Status: Recruiting
• Phase: N/A
• Start date: March 7, 2023
• Completion date: March 21, 2025